News

Sarepta Therapeutics falls sharply after suspending shipments of Elevidys for infusions in non-ambulatory patients because of ...
Supernus Pharmaceuticals (SUPN) acquires Sage Therapeutics (SAGE), enhancing its CNS portfolio with Zurzuvae's potential.
Sage Therapeutics Inc. has found itself a buyer that bested the unsolicited acquisition offer a few months ago from fellow ...
Supernus Pharmaceuticals (NASDAQ:SUPN) has agreed to acquire depression drugmaker Sage Therapeutics (NASDAQ:SAGE) for a total ...
This year's Head of School award went to graduating seniors Fiori Lee of Irvine and Courtney Tetteh-Martey of Newport Coast ...
“She spent nearly 650 days in a loving foster home while she patiently waited for a home of her very own,” the Triangle ...
Stifel analysts said the deal “feels like an unremarkable outcome for a company that was once one of the hottest stories in ...
Wisconsin Senate Sergeant at Arms Timothy La Sage announced his office will be enacting "a series of enhanced security ...
The terms include an upfront payment of $8.50 per share for Sage, giving Supernus rights to its FDA-approved post-partum ...
Kristen Ford, Rachael Sage, Carissa Johnson, and Sarah Donner will play Electric Haze stage on June 22. Tickets cost $15 ...
Neurology specialist Supernus Pharmaceuticals will snap up Sage Therapeutics, which was once valued at more than $9 billion, ...
After rejecting a buyout offer from its partner Biogen, the Cambridge firm is being acquired by Supernus Pharmaceuticals.